Consistently, transgenic mouse lines bearing varying levels of wild-type PTEN overexpression acquired anticancer protective features through a healthy metabolism switch, thus opening a route for novel treatment modalities for cancer prevention and therapy [10]. The gene discussed is PTEN; the disease is cancer.